Assessment of Heterologous and Homologous Boosting With Inactivated COVID-19 Vaccine at 3 Months Compared With Homologous Boosting of BNT162b2 at 6 Months
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.26046
Abstract: Key Points Question What are the risks of SARS-CoV-2 infection associated with heterologous and homologous boosting of CoronaVac at 3 months compared with homologous boosting of BNT162b2 at 6 months? Findings In this cohort study… read more here.
Keywords: bnt162b2 months; homologous boosting; months compared; compared homologous ... See more keywords